Literature DB >> 6315421

Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin.

B S van Asbeck, J H Marcelis, J H van Kats, E Y Jaarsma, J Verhoef.   

Abstract

Synergy between the iron chelator deferoxamine in the presence or absence of ascorbic acid and gentamicin, chloramphenicol, cephalothin, cefotiam or cefsulodin, used against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Klebsiella pneumoniae, proteus mirabilis and species of Salmonella, Enterobacter, Pseudomonas and Providencia, was determined by measuring the effect of the drugs and combination of drugs on growth of the bacteria in an automated turbidimeter. The combination of drugs was considered to be synergistic when the growth inhibiting effect of the combination was greater than that of the combined action of each of the drugs separately. Deferoxamine plus ascorbic acid together with either gentamicin or cefsulodin showed synergy in 10 out of 10, and 5 out of 6 cultures respectively, whereas deferoxamine plus ascorbic acid with chloramphenicol, cephalothin or cefotiam was synergistic in 6 out of 14, 5 out of 11, and 3 out of 6 cultures. This synergistic effect was much lower when microorganisms were incubated with deferoxamine combined with the various antibiotics but without ascorbic acid. Ascorbic acid alone had no synergistic effect. When deferoxamine was saturated with iron, its antibacterial effect was completely abolished.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315421     DOI: 10.1007/bf02013900

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  15 in total

1.  THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM.

Authors:  H KEBERLE
Journal:  Ann N Y Acad Sci       Date:  1964-10-07       Impact factor: 5.691

Review 2.  Iron and infection.

Authors:  E D Weinberg
Journal:  Microbiol Rev       Date:  1978-03

Review 3.  Evaluation of desferrioxamine and ascorbic acid for the treatment of chronic iron overload.

Authors:  A W Nienhuis; C Delea; R Aamodt; F Bartter; W F Anderson
Journal:  Birth Defects Orig Artic Ser       Date:  1976

4.  Comparative effectiveness of combinations of amikacin with penicillin G and amikacin with carbenicillin in gram-negative septicemia: double-blind clinical trial.

Authors:  J Klastersky; C Hensgens; F Meunier-Carpentier
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

5.  Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload.

Authors:  B S van Asbeck; H A Verbrugh; B A van Oost; J J Marx; H W Imhof; J Verhoef
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-20

6.  Semielectronic turbidimeter for automated monitoring of bacterial growth in test tubes.

Authors:  J H Marcelis; H Versteeg; H J Beck; D Vinke
Journal:  Appl Environ Microbiol       Date:  1980-02       Impact factor: 4.792

7.  The assessment of antimicrobial combinations.

Authors:  T C King; D Schlessinger; D J Krogstad
Journal:  Rev Infect Dis       Date:  1981 May-Jun

8.  Vitamin C and iron.

Authors:  A W Nienhuis
Journal:  N Engl J Med       Date:  1981-01-15       Impact factor: 91.245

9.  The critical role of iron in host-bacterial interactions.

Authors:  S M Payne; R A Finkelstein
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

10.  Inhibition of bacterial multiplication by the iron chelator deferoxamine: potentiating effect of ascorbic acid.

Authors:  B S van Asbeck; J H Marcelis; J J Marx; A Struyvenberg; J H van Kats; J Verhoef
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

View more
  8 in total

1.  In vitro antimicrobial properties of deferoxamine mesylate.

Authors:  D J Flournoy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-07       Impact factor: 3.267

2.  In vitro time-kill activities of ciprofloxacin alone and in combination with the iron chelator deferasirox against Vibrio vulnificus.

Authors:  G P Neupane; D-M Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-02-02       Impact factor: 3.267

3.  Gallium Potentiates the Antibacterial Effect of Gentamicin against Francisella tularensis.

Authors:  Helena Lindgren; Anders Sjöstedt
Journal:  Antimicrob Agents Chemother       Date:  2015-10-26       Impact factor: 5.191

4.  The effect of iron loading and iron chelation on the innate immune response and subclinical organ injury during human endotoxemia: a randomized trial.

Authors:  Lucas T van Eijk; Suzanne Heemskerk; Rob W van der Pluijm; Susanne M van Wijk; Wilbert H M Peters; Johannes G van der Hoeven; Matthijs Kox; Dorine W Swinkels; Peter Pickkers
Journal:  Haematologica       Date:  2013-11-15       Impact factor: 9.941

5.  Biofilm-specific uptake of a 4-pyridone-based iron chelator by Pseudomonas aeruginosa.

Authors:  Sharareh Houshmandyar; Ian M Eggleston; Albert Bolhuis
Journal:  Biometals       Date:  2021-01-11       Impact factor: 2.949

6.  Effect of iron-chelator deferiprone on the in vitro growth of staphylococci.

Authors:  Choon-Mee Kim; Sung-Heui Shin
Journal:  J Korean Med Sci       Date:  2009-04-20       Impact factor: 2.153

7.  Activity of siderophores against drug-resistant Gram-positive and Gram-negative bacteria.

Authors:  Karuna Gokarn; Ramprasad B Pal
Journal:  Infect Drug Resist       Date:  2018-01-09       Impact factor: 4.003

Review 8.  Tuning the Anti(myco)bacterial Activity of 3-Hydroxy-4-pyridinone Chelators through Fluorophores.

Authors:  Maria Rangel; Tânia Moniz; André M N Silva; Andreia Leite
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.